MedPage Today3d
Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i
The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
Managed Healthcare Executive3d
Monoclonal Antibody Bentracimab Shown to Reverse Antiplatelet Effect of Brilinta | ACC 2025
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
Mirage News3d
Monoclonal Antibody Reverses Heart Attack Drug Effects
An investigational monoclonal antibody called bentracimab can safely and effectively reverse potentially catastrophic ...
Ticagrelor antidote safely, effectively restores platelet function and treats bleeding
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's ...
The American Journal of Managed Care6d
Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
The Manila Times6d
Former White House Advisor: President Trump Could Unlock $150 Trillion in Untapped U.S. Resources
In a groundbreaking initiative, former President Donald Trump is poised to unveil a $150 trillion national 'endowment”, a move that could redefine the economic landscape of the United States. This ...